Ultra Low Temperature Freezer Market

Ultra-low temperature freezers are bio-coolers whose temperature ranges from -40°C, -86°C down to -150°C. The growth and development in the research sector such as biomedical and life sciences and increasing demand for blood bank storage lead to the market growth of ultra-low temperature freezers. These ULT freezers are also used on a large scale by pharmaceutical companies for drug discovery and clinical testing processes. These are also used to preserve drugs, chemicals, viruses, bacteria, enzymes, cell preparations, and tissue samples. The development of energy-saving ultra-low temperature freezers is expected to create future opportunities in this market.

The market is segmented on the basis of type, degree of cooling, application, end user, and region. Based on type, the market is segmented into upright ULT freezers and chest ULT freezers. The upright ULT freezers are further sub-segmented into floor standing and benchtop/undercounter. On the basis of the degree of cooling the ULT freezers are segmented into -41°C to -86° C Freezers and -87°C to -150° C Freezers. By application, the market is segmented into blood & blood products, biological samples, drug compounds, and others. On the basis of end user, the market is segmented into biobanks, hospitals and clinics, academic and research institutes, and others. Geographically, it has been analyzed across North America, Europe, Asia-Pacific, and the Middle East and Africa.

The key players that operate in the market include Thermo Fisher Scientific Inc., Helmer Scientific, Stirling Ultracold, Global Cooling Inc., Eppendorf AG., VWR International, PHC Corporation, Esco Micro Pte Ltd., BINDER GmbH, Labcold, and Arctiko. The key factors that drive the ultra-low temperature freezers market are increasing research and development using tissue culture technology, growing blood banks, and rising adoption of new technology in healthcare. However, factors such as high costs of ultra-low temperature freezers hinder market growth.